Prestige Wealth Management Group’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.98K Hold
760
﹤0.01% 509
2026
Q1
$8.23K Hold
760
﹤0.01% 462
2025
Q4
$4.64K Buy
760
+582
+327% +$3.48K ﹤0.01% 594
2025
Q3
$923 Buy
+178
New +$1.02K ﹤0.01% 858
2025
Q2
Sell
-334
Closed -$2.75K 1054
2025
Q1
$2.75K Buy
334
+203
+155% +$1.7K ﹤0.01% 680
2024
Q4
$1.08K Buy
+131
New +$1.05K ﹤0.01% 872
2024
Q3
Sell
-228
Closed -$2.36K 1045
2024
Q2
$2.36K Buy
228
+74
+48% +$811 ﹤0.01% 688
2024
Q1
$1.84K Buy
+154
New +$1.71K ﹤0.01% 765

Other funds holding PTEN

Prestige Wealth Management Group's PTEN Position: Q2 2026 in Review

Prestige Wealth Management Group held its Patterson-UTI (PTEN) position steady in Q2 2026 at 760 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Prestige Wealth Management Group first reported a position in PTEN in Q1 2024 and has held it in 8 quarters since. The position peaked at $8.23K in Q1 2026. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Prestige Wealth Management Group held 760 shares of Patterson-UTI worth $6.98K as of Q2 2026.
  • Prestige Wealth Management Group left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #509 holding.
  • Prestige Wealth Management Group first reported a position in Patterson-UTI in Q1 2024 and has held it in 8 quarters since.
  • Prestige Wealth Management Group's Patterson-UTI position peaked at $8.23K in Q1 2026.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.